procaterol has been researched along with Heart Disease, Ischemic in 2 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of dopexamine hydrochloride(DPX) on cardiac hemodynamics during acute myocardial ischemia (AMI) was studied in rats and compared with those of fenoldopam hydrochloride(FODA) and procaterol hydrochloride (PCT)." | 7.70 | [Effects of dopexamine on cardiac hemodynamics during myocardial ischemia in rats and in comparison with fenoldopam and procaterol]. ( Chen, J; Qin, F; Zhang, W; Zhao, R, 1998) |
| "The effects of dopexamine (DPX), a new dopamine receptor agonist, on transmembrane potential and effective refractory period (ERP) of isolated guinea pig ventricular muscle superfused either with hypoxia or mimic ischemia perfusates were investigated by using intracellular microelectrode technique and compared with fenoldopam (FODA) and procaterol." | 7.69 | [Effects of dopexamine on the electrophysiologic changes during myocardial ischemia and comparison with fenoldopam and procaterol]. ( Qin, FZ; Wang, WZ; Wu, BW; Zhao, RR; Zhu, L, 1995) |
| "The effect of dopexamine hydrochloride(DPX) on cardiac hemodynamics during acute myocardial ischemia (AMI) was studied in rats and compared with those of fenoldopam hydrochloride(FODA) and procaterol hydrochloride (PCT)." | 3.70 | [Effects of dopexamine on cardiac hemodynamics during myocardial ischemia in rats and in comparison with fenoldopam and procaterol]. ( Chen, J; Qin, F; Zhang, W; Zhao, R, 1998) |
| "The effects of dopexamine (DPX), a new dopamine receptor agonist, on transmembrane potential and effective refractory period (ERP) of isolated guinea pig ventricular muscle superfused either with hypoxia or mimic ischemia perfusates were investigated by using intracellular microelectrode technique and compared with fenoldopam (FODA) and procaterol." | 3.69 | [Effects of dopexamine on the electrophysiologic changes during myocardial ischemia and comparison with fenoldopam and procaterol]. ( Qin, FZ; Wang, WZ; Wu, BW; Zhao, RR; Zhu, L, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, FZ | 1 |
| Zhao, RR | 1 |
| Zhu, L | 1 |
| Wang, WZ | 1 |
| Wu, BW | 1 |
| Qin, F | 1 |
| Zhang, W | 1 |
| Zhao, R | 1 |
| Chen, J | 1 |
2 other studies available for procaterol and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Effects of dopexamine on the electrophysiologic changes during myocardial ischemia and comparison with fenoldopam and procaterol].
Topics: Action Potentials; Animals; Dopamine; Dopamine Agonists; Female; Fenoldopam; Guinea Pigs; Hypoxia; I | 1995 |
[Effects of dopexamine on cardiac hemodynamics during myocardial ischemia in rats and in comparison with fenoldopam and procaterol].
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Dopamine; Dopamine Agonists; Female; Fenoldopam; Hemod | 1998 |